KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Stock Information for Apyx Medical Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Apyx Medical Corporation

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance
KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.